☰

Arielle Butts, Ph.D. - Publications

Affiliations: 
2013 School of Arts and Sciences University of Rochester, Rochester, NY 
Area:
Molecular Chemistry, Microbiology Biology, Organic Chemistry
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Njikan S, Ahmed S, Manning A, Awasthi D, Ovechkina Y, Chowdhury S, Butts A, Parish T. Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular . Microbiology Spectrum. e0116122. PMID 35612308 DOI: 10.1128/spectrum.01161-22  0.362
2019 Butts A, Reitler P, Nishimoto AT, DeJarnette C, Estredge LR, Peters TL, Veve MP, Rogers PD, Palmer GE. A systematic screen reveals a diverse collection of medications induce antifungal resistance in species. Antimicrobial Agents and Chemotherapy. PMID 30858206 DOI: 10.1128/Aac.00054-19  0.49
2018 Luna-Tapia A, Butts A, Palmer GE. Loss of C-5 sterol desaturase activity in - azole resistance or merely trailing growth? Antimicrobial Agents and Chemotherapy. PMID 30323044 DOI: 10.1128/Aac.01337-18  0.302
2018 Butts A, Reitler P, Ge W, Fortwendel JR, Palmer GE. Commonly used oncology drugs decrease antifungal effectiveness against and species. Antimicrobial Agents and Chemotherapy. PMID 29712657 DOI: 10.1128/Aac.00504-18  0.507
2017 Butts A, DeJarnette C, Peters TL, Parker JE, Kerns ME, Eberle KE, Kelly SL, Palmer GE. Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. Msphere. 2. PMID 28989971 DOI: 10.1128/mSphere.00379-17  0.302
2016 Butts A, Palmer GE, Rogers PD. Antifungal adjuvants: preserving and extending the antifungal arsenal. Virulence. 0. PMID 27459018 DOI: 10.1080/21505594.2016.1216283  0.448
2015 Butts A, Martin JA, DiDone L, Bradley EK, Mutz M, Krysan DJ. Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen. Plos One. 10: e0125927. PMID 26016941 DOI: 10.1371/Journal.Pone.0125927  0.552
2014 Brown JC, Nelson J, VanderSluis B, Deshpande R, Butts A, Kagan S, Polacheck I, Krysan DJ, Myers CL, Madhani HD. Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell. 159: 1168-87. PMID 25416953 DOI: 10.1016/J.Cell.2014.10.044  0.538
2014 Butts A, Koselny K, Chabrier-Roselló Y, Semighini CP, Brown JC, Wang X, Annadurai S, DiDone L, Tabroff J, Childers WE, Abou-Gharbia M, Wellington M, Cardenas ME, Madhani HD, Heitman J, et al. Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. Mbio. 5: e00765-13. PMID 24520056 DOI: 10.1128/Mbio.00765-13  0.601
2013 Butts A, DiDone L, Koselny K, Baxter BK, Chabrier-Rosello Y, Wellington M, Krysan DJ. A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryotic Cell. 12: 278-87. PMID 23243064 DOI: 10.1128/Ec.00314-12  0.598
2012 Butts A, Krysan DJ. Antifungal drug discovery: something old and something new. Plos Pathogens. 8: e1002870. PMID 22969422 DOI: 10.1371/Journal.Ppat.1002870  0.554
Show low-probability matches.